Guanabenz acetate salt
SIGMA/G110 - powder
Synonym: 1-
CAS Number: 23256-50-0
Empirical Formula (Hill Notation): C8H8Cl2N4 · C2H4O2
Molecular Weight: 291.13
EC Number: 245-534-7
MDL Number: MFCD00153801
Linear Formula: C8H8Cl2N4 · C2H4O2
Product Type: Chemical
| color | white |
| form | powder |
| InChI | 1S/C8H8Cl2N4.C2H4O2/c9-6- |
| InChI key | MCSPBPXATWBACD-GAYQJXMFSA |
| originator | Wyeth |
| Quality Level | 200 ![]() |
| SMILES string | CC(O)=O.NC(=N)NN=Cc1c(C |
| solubility | alcohol: 50 mg/mL |
| H2O: 10 mg/mL |
| Biochem/physiol Actions: | Centrally acting α2 adrenoceptor agonist; I2 imidazoline binding site ligand; antihypertensive. |
| Features and Benefits: | This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the α2-Adrenoceptors and Imidazoline Binding Sites pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Wyeth . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 100, 500 mg in glass bottle |
| Packaging: | 25 mg in poly bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 22-36/37/39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |


